PAhR Therapeutics is a clinical-stage biotech company advancing innovative therapies to treat pulmonary arterial hypertension (PAH) through novel biological mechanisms.
Investors 1
Mentions in press and media 2
| Date | Title | Description |
| 29.07.2025 | Pahr Therapeutics Raises $14M in Seed Funding | Pahr Therapeutics, a Boston, MA- and Osaka, Japan-based clinical stage company developing therapies for PAH, raised $14M in Seed funding.
The round was led by RA Capital Management, AN Venture Partners and University of Tokyo Edge Capital P... |
| - | Pahr Therapeutics | “PAhR Therapeutics is a clinical-stage biotech company advancing innovative therapies to treat pulmonary arterial hypertension (PAH) through novel biological mechanisms.” |
Reviews 0
